Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Behavioral therapy vs parenteral methotrexate vs standard care for methotrexate intolerance in juvenile idiopathic arthritis
2006-006812-31Phase 4Completed
- Sponsor
- University Medical Center Utrecht
- Start
- Jun 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of methotrexate in juvenile idiopathic arthritis (JIA) and Methotrexate intolerance (MTXI) (3 arms), sponsored by University Medical Center Utrecht. Primary endpoint: Incidence of methotrexate intolerance. Started Jun 2007; status: completed.
02
Drugs
methotrexate
03
Conditions
juvenile idiopathic arthritis (JIA)Methotrexate intolerance (MTXI)
Beyond the preview
Go deeper on 2006-006812-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006812-31.